Structures by: Low J. N.
Total: 892
2-amino-6-(methylanilino)pyrimidin-4(3H)-one
C11H12N4O
Acta Crystallographica Section C (2007) 63, 12 o697-o700
a=10.6860(12)Å b=7.1647(14)Å c=14.4911(12)Å
α=90.00° β=110.024(9)° γ=90.00°
2-amino-6-(methylanilino)-5-nitropyrimidin-4(3H)-one
C11H11N5O3
Acta Crystallographica Section C (2007) 63, 12 o697-o700
a=8.955(3)Å b=11.2165(15)Å c=11.5670(15)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-3-{2-Amino-4-ethoxy-6-[<i>N</i>-(4-methoxyphenyl)-N- methylamino]pyrimidin-5-yl}-1-phenylprop-2-en-1-one
C23H24N4O3
Acta Crystallographica Section C (2007) 63, 12 o758-o760
a=10.1975(14)Å b=10.959(2)Å c=11.046(2)Å
α=94.079(16)° β=109.845(11)° γ=113.339(10)°
7-(4-chlorophenyl)-2-ethylsulfanyl-4-phenylpyrazolo[1,5-a][1,3,5]triazine
C19H15ClN4S
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=11.8290(10)Å b=7.5703(5)Å c=19.5297(5)Å
α=90.00° β=107.200(3)° γ=90.00°
4,7-bis(4-chlorophenyl)-2-(ethylsulfanyl)pyrazolo[1,5-a][1,3,5]triazine
C19H14Cl2N4S
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=7.7117(4)Å b=8.3261(10)Å c=27.678(3)Å
α=90.00° β=94.978(5)° γ=90.00°
2-ethylsulfanyl-7-(4-methylphenyl)-4-phenylpyrazolo[1,5-a][1,3,5]triazine
C20H18N4S
Acta Crystallographica Section C (2008) 64, 1 o27-o30
a=4.8076(3)Å b=11.6397(5)Å c=15.5010(7)Å
α=92.164(4)° β=96.217(5)° γ=100.087(4)°
Ethyl (E)-3-[2-amino-4,6-bis(dimethylamino)pyrimidin-5-yl]-2-cyanoacrylate
C14H20N6O2
Acta Crystallographica Section C (2008) 64, 3 o145-o148
a=8.5570(15)Å b=9.893(2)Å c=9.9739(18)Å
α=87.534(13)° β=77.251(15)° γ=67.431(14)°
2-[(2-amino-4,6-di-1-piperidylpyrimidin-5-yl)methylene]malononitrile
C18H23N7
Acta Crystallographica Section C (2008) 64, 3 o145-o148
a=9.6960(8)Å b=14.752(3)Å c=15.418(3)Å
α=116.332(13)° β=96.794(10)° γ=93.587(9)°
Dispiro[indene-2,5'-indeno[2,1-a]fluorene-6',2''-indene]- 1,1'',3,3'',11',12'-hexaone
C36H16O6
Acta Crystallographica Section C (2008) 64, 3 o162-o165
a=8.2209(11)Å b=16.552(3)Å c=18.423(3)Å
α=90.00° β=97.775(19)° γ=90.00°
6-amino-3-methyl-2-(morpholin-4-yl)-5-nitrosopyrimidin-4(3H)-one
C9H13N5O3
Acta Crystallographica Section C (2008) 64, 4 o220-o225
a=8.9122(6)Å b=11.9051(7)Å c=10.4111(4)Å
α=90.00° β=105.649(3)° γ=90.00°
6-amino-2-(morpholin-4-yl)-5-nitrosopyrimidin-4(3H)-one hemihydrate
C8H11N5O3,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 4 o220-o225
a=16.421(2)Å b=7.3671(12)Å c=17.205(4)Å
α=90.00° β=104.794(12)° γ=90.00°
Ethyl 2-methoxy-6-[(triphenylphosphoranylidene)amino]nicotinate
C27H25N2O3P
Acta Crystallographica Section C (2008) 64, 4 o233-o236
a=8.5336(18)Å b=11.063(3)Å c=13.426(3)Å
α=73.722(18)° β=72.389(16)° γ=85.93(2)°
Ethyl 2-methylsulfanyl-6-[(triphenylphosphoranylidene)amino]nicotinate
C27H25N2O2PS
Acta Crystallographica Section C (2008) 64, 4 o233-o236
a=8.5671(14)Å b=11.0617(6)Å c=13.547(2)Å
α=102.987(8)° β=106.417(12)° γ=94.596(10)°
2-(<i>tert</i>-Butylamino)-4-chloro-6-ethylamino-1,3,5-triazine
C9H16ClN5
Acta Crystallographica Section C (2008) 64, 8 o463-o466
a=23.557(3)Å b=9.9789(15)Å c=20.3594(17)Å
α=90.00° β=90.00° γ=90.00°
(2SR,4RS)-7-Chloro-2-<i>exo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=10.5798(8)Å b=5.3448(10)Å c=12.873(3)Å
α=90.00° β=90.204(12)° γ=90.00°
(2RS,4RS)-7-Chloro-2-<i>endo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.2855(10)Å b=15.649(2)Å c=17.880(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>,4<i>R</i>)-7-fluoro-2-endo-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16FNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.4172(2)Å b=8.0164(6)Å c=16.2310(11)Å
α=90.00° β=96.745(4)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-trifluoromethoxy- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C15H11BrF3NO2S
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.6913(6)Å b=10.1187(6)Å c=13.2996(13)Å
α=90.00° β=100.497(8)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>-(2-chlorophenyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=7.4328(11)Å b=12.3746(16)Å c=14.9187(19)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>- (1-naphthyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C20H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=9.6174(18)Å b=11.558(3)Å c=13.465(4)Å
α=90.00° β=90.00° γ=90.00°
9-Benzoyl-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione
C24H26O4
Acta Crystallographica Section C (2008) 64, 10 o554-o557
a=11.6394(15)Å b=11.5736(15)Å c=30.782(4)Å
α=90.00° β=90.00° γ=90.00°
Trans-Tetraaquadichloridocobalt(II)--piperazine-2,5-dione (1/1)
Cl2CoH8O4,C4H6N2O2
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=9.5326(4)Å b=6.6602(2)Å c=10.0167(4)Å
α=90.00° β=114.1660(17)° γ=90.00°
Silver(I) nitrate--piperazine-2.5-dione (1/1)
C8H12Ag2N6O10
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=9.62760(10)Å b=14.7180(2)Å c=5.2468(4)Å
α=90.00° β=90.00° γ=90.00°
<i>catena</i>-poly[[[<i>trans</i>-diaquacopper(II)]-di-μ-chlorido] piperazine-2,5-dione solvate]
Cl2CuH4O2,2C2H3NO
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=15.224(3)Å b=3.9694(8)Å c=15.444(4)Å
α=90.00° β=94.73(3)° γ=90.00°
(2SR,4RS)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-fluoro- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C14H11BrFNOS
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=8.1835(6)Å b=10.9447(8)Å c=14.6940(12)Å
α=90.00° β=104.969(6)° γ=90.00°
(2SR,4RS)-7-Fluoro-2-<i>exo</i>-(2-furyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy- 1-benzazepine
C14H12FNO2
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.5314(10)Å b=15.430(4)Å c=26.229(6)Å
α=90.00° β=92.960(17)° γ=90.00°
Hexamethylenediammonium bis(chloroacetate)
C6H18N22,2C2H2ClO2
Acta Crystallographica Section C (2008) 64, 9 o505-o507
a=6.5779(18)Å b=7.3593(10)Å c=8.425(2)Å
α=97.277(12)° β=95.631(15)° γ=111.037(12)°
(2SR,4RS)-7-chloro-2-<i>exo</i>-(4-chlorophenyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=11.9348(11)Å b=21.617(2)Å c=5.3024(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2-Methoxyphenyl)-4-oxo-4<i>H</i>-chromone-3-carboxamide
C17H13NO4
Acta Crystallographica Section C (2013) 69, 8 927-933
a=8.9867(18)Å b=20.669(4)Å c=14.856(3)Å
α=90.00° β=93.545(4)° γ=90.00°
<i>N</i>-(2-Methoxyphenyl)-4-oxo-4<i>H</i>-chromone-3-carboxamide
C17H13NO4
Acta Crystallographica Section C (2013) 69, 8 927-933
a=14.614(13)Å b=23.95(2)Å c=8.125(7)Å
α=90.00° β=102.069(17)° γ=90.00°
(<i>E</i>)-1-Phenylbutan-2-one (2,4-dinitrophenyl)hydrazone
C16H16N4O4
Acta Crystallographica Section E (2009) 65, 11 o2729
a=15.8919(13)Å b=4.9446(3)Å c=20.7397(17)Å
α=90.00° β=105.267(5)° γ=90.00°
4-(1-Naphthyl)benzonitrile
C17H11N1
Acta Crystallographica Section E (2010) 66, 12 o3289
a=7.3387(3)Å b=11.3461(5)Å c=15.5804(7)Å
α=71.237(2)° β=89.981(2)° γ=87.647(2)°
1,3-Diphenylpropan-2-one (2,4-dinitrophenyl)hydrazone
C21H18N4O4
Acta Crystallographica Section E (2010) 66, 3 o565
a=17.2448(9)Å b=5.1013(2)Å c=22.7459(13)Å
α=90.00° β=109.475(2)° γ=90.00°
4-(1-Naphthyl)benzoic acid
C17H12O2
Acta Crystallographica Section E (2009) 65, 12 o3037
a=3.8972(6)Å b=40.511(6)Å c=7.6106(12)Å
α=90.00° β=99.323(3)° γ=90.00°
<i>N</i>'-benzoyl-<i>N</i>,<i>N</i>-diethylthiourea
C12H16N2OS
Acta Crystallographica Section E (2010) 66, 4 o870
a=20.1727(7)Å b=8.4717(3)Å c=14.8345(6)Å
α=90.00° β=106.553(2)° γ=90.00°
3,3'-bithiophene
C8H6S2
Acta Crystallographica Section E (2010) 66, 4 o916
a=7.5187(7)Å b=18.2181(17)Å c=5.5029(5)Å
α=90.00° β=90.00° γ=90.00°
4,4'-(1,8-Naphthalene-1,8-diyl)dibenzonitrile
C24H14N2
Acta Crystallographica Section E (2011) 67, 1 o66
a=17.0872(9)Å b=8.2997(4)Å c=24.3656(13)Å
α=90.00° β=93.795(2)° γ=90.00°
<i>N</i>-(diethylaminothiocarbonyl)-<i>N</i>'-phenylbenzamidine
C18H21N3S
Acta Crystallographica Section E (2011) 67, 4 o962-o963
a=21.2894(8)Å b=18.8015(7)Å c=27.1792(10)Å
α=90.00° β=128.584(2)° γ=90.00°
(<i>E</i>)-4-Hydroxy-<i>N</i>'-(3-hydroxybenzylidene)benzohydrazide monohydrate
C14H12N2O3,H2O
Acta Crystallographica Section E (2014) 70, 9 o891-o892
a=7.1826(5)Å b=9.2043(6)Å c=10.7568(7)Å
α=91.847(7)° β=102.433(7)° γ=110.191(8)°
2,4,5-Tris(biphenyl-2-yl)-1-bromobenzene
C42H29Br
Acta Crystallographica Section E (2011) 67, 8 o2090-o2091
a=11.6723(5)Å b=12.2455(6)Å c=12.4859(6)Å
α=62.549(2)° β=70.771(2)° γ=79.407(2)°
1,3-diisopropyl-naphthalene
C16H20
Acta Crystallographica Section E (2011) 67, 12 o3334
a=16.1044(12)Å b=8.2099(5)Å c=19.0303(13)Å
α=90.00° β=90.00° γ=90.00°
S-(2-Nitrophenyl) 2-nitrobenzene thiosulfonate
C12H8N2O6S2
Acta Crystallographica Section B (2000) 56, 5 893-905
a=8.8211(18)Å b=11.042(2)Å c=21.258(4)Å
α=101.06(3)° β=91.97(3)° γ=91.07(3)°
2,4-Dinitro-4'-methyldiphenyl disulfide
C13H10N2O4S2
Acta Crystallographica Section B (2000) 56, 5 893-905
a=10.1301(2)Å b=6.34740(10)Å c=11.1133(2)Å
α=90.00° β=106.644(8)° γ=90.00°
2-Nitrobenzylidene-2'-iodoaniline
C13H9IN2O2
Acta Crystallographica Section B (2002) 58, 5 864-876
a=8.0664(4)Å b=10.7191(5)Å c=14.5692(9)Å
α=90.00° β=99.026(2)° γ=90.00°
4-Nitrobenzylidene-2'-iodoanilinb-Nitrobenzylidene-2'-iodoanilin
C13H9IN2O2
Acta Crystallographica Section B (2002) 58, 5 864-876
a=10.1401(7)Å b=13.7454(10)Å c=9.7829(6)Å
α=90.00° β=113.961(4)° γ=90.00°
4-oxo-N-(2-nitrophenyl)-4H-chromene-2-carboxamide
C16H10N2O5
Acta Crystallographica Section B (2013) 69, 3 294-309
a=12.3425(10)Å b=5.885(4)Å c=18.316(15)Å
α=90.00° β=99.543(13)° γ=90.00°
N-(4-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.0039(3)Å b=5.6916(2)Å c=13.3466(3)Å
α=90.00° β=101.6381(12)° γ=90.00°
N-(2-methyl-5-nitrophenyl)pyrazinecarboxamide
C12H10N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.4767(5)Å b=14.5930(6)Å c=7.7136(3)Å
α=90.00° β=93.433(3)° γ=90.00°
2,4-Diiodo-3-nitroaniline
C6H4I2N2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=7.6069(3)Å b=12.5917(4)Å c=10.2546(3)Å
α=90.00° β=106.6693(16)° γ=90.00°
2,2,3,3'-Tetraacetato-6,6'-bis(N-acetylamino)-α,α'-trehalose dihydrate
C24H36N2O15,2(H2O)
Acta Crystallographica Section B (2004) 60, 4 461-471
a=8.8385(2)Å b=21.8363(8)Å c=8.0831(2)Å
α=90.00° β=90.00° γ=90.00°
(4-(Pyrrolidin-1-yl)-1/H/-pyrazolo[3,4-/d/]pyrimidin-6-amine) ethanol hemisolvate hemihydrate
2(C9H12N6),C2H6O,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.9342(15)Å b=8.9219(19)Å c=16.767(3)Å
α=76.855(16)° β=83.505(14)° γ=88.003(17)°
Saccharin
C7H5NO3S
Acta Crystallographica Section E (2005) 61, 6 o1944-o1946
a=9.4722(4)Å b=6.9227(2)Å c=11.7322(3)Å
α=90.00° β=103.203(3)° γ=90.00°
6-Amino-5-N-acetyl-N-(β-D-3,4,6-tri-O-acetylglucopyranosyl)amino- 2,4-dioxo-1,2,3,4-tetrahydro-3-methylpyrimidine, water solvent
C19H26N4O11,H2O
Acta Crystallographica Section C (1999) 55, 12 IUC9900164
a=14.3951(11)Å b=8.9771(9)Å c=19.052(2)Å
α=90.00° β=90.00° γ=90.00°
Bis[N,N-diisobutyl-N'-(2-thienylcarbonyl)thioureato]copper(II)
C28H42Cu1N4O2S4
Acta Crystallographica Section E (2007) 63, 4 m956-m958
a=13.1693(6)Å b=13.1693(6)Å c=20.2499(16)Å
α=90.00° β=90.00° γ=90.00°
N,N'-Dithiodiphthalimide
C16H8N2O4S2
Acta Crystallographica Section C (2001) 57, 6 742-746
a=14.3782(13)Å b=16.0723(14)Å c=7.7910(7)Å
α=90° β=93.256(2)° γ=90°
N-(3-Nitrophenyl)phthalimide
C14H8N2O4
Acta Crystallographica Section C (2004) 60, 1 o24-o27
a=6.6650(5)Å b=3.6962(3)Å c=23.639(2)Å
α=90° β=95.208(3)° γ=90°
2-Methanesulfonyl-4-nitroaniline
C7H8N2O4S
Acta Crystallographica Section C (2004) 60, 1 o84-o86
a=15.8657(5)Å b=7.23660(10)Å c=16.4224(5)Å
α=90° β=110.3040(10)° γ=90°
N-methyl-2-phenoxybenzenesulfonamide
C13H13NO3S
Acta Crystallographica Section C (2004) 60, 5 o364-o367
a=5.3804(2)Å b=7.9959(4)Å c=14.4462(7)Å
α=90.00° β=95.226(2)° γ=90.00°
Rac-5-benzoyl-2,3,4,5-tetrahydro-2,2,4-trimethyl-1,5-benzothiazepine
C19H21NOS
Acta Crystallographica Section C (2004) 60, 5 o346-o349
a=16.1757(2)Å b=12.5444(3)Å c=8.2147(2)Å
α=90.00° β=90.00° γ=90.00°
3-iodo-N-(2-nitrobenzylidene)aniline
C13H9IN2O2
Acta Crystallographica Section C (2005) 61, 7 o445-o449
a=12.5676(4)Å b=7.8818(2)Å c=13.5110(4)Å
α=90.00° β=109.6328(13)° γ=90.00°
4,6-Dimethoxy-2-phthalimidopyrimidine
C14H11N3O4
Acta Crystallographica Section C (2008) 64, 7 o392-o394
a=7.2904(8)Å b=13.896(2)Å c=12.5021(11)Å
α=90.00° β=96.476(7)° γ=90.00°
2-Amino-4-chloro-6-[<i>N</i>-methyl-<i>N</i>-(4-methylphenyl)amino]pyrimidine
C12H13ClN4
Acta Crystallographica Section C (2008) 64, 7 o376-o378
a=9.8184(5)Å b=7.8683(7)Å c=15.5719(16)Å
α=90.00° β=100.309(7)° γ=90.00°
6-(4-Bromophenyl)-6,7-dihydro-1,3-dioxolo[4,5-g]quinolin-8(5H)-one
C16H12BrNO3
Acta Crystallographica Section C (2004) 60, 11 o827-o829
a=21.2470(11)Å b=5.8263(3)Å c=11.4131(6)Å
α=90.00° β=98.197(3)° γ=90.00°
2-amino-3-bromo-5-nitrobenzonitrile
C7H4BrN3O2
Acta Crystallographica Section C (2002) 58, 2 o100-o102
a=4.2494(2)Å b=14.9094(7)Å c=13.0958(7)Å
α=90° β=96.138(2)° γ=90°
5-[1-(benzylamino)ethylidene]-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
C15H17N3O3
Acta Crystallographica Section C (2005) 61, 1 o15-o20
a=7.0696(5)Å b=9.0734(7)Å c=11.9214(8)Å
α=70.995(2)° β=82.084(2)° γ=84.729(2)°
N,N'-bis(4-nitrobenzylidene)propane-1,3-diamine
C17H16N4O4
Acta Crystallographica Section C (2005) 61, 1 o53-o56
a=12.9412(6)Å b=7.3062(3)Å c=16.9061(8)Å
α=90.00° β=99.559(2)° γ=90.00°
N-Phenyl-4-nitrophthalimide
C14H8N2O4
Acta Crystallographica Section C (2005) 61, 4 o209-o210
a=11.9288(6)Å b=7.0604(2)Å c=13.8337(7)Å
α=90.00° β=90.00° γ=90.00°
2-Chloro-N-(4-nitrophenyl)nicotinamide
C12H8ClN3O3
Acta Crystallographica Section C (2005) 61, 4 o204-o208
a=7.2385(2)Å b=24.5094(6)Å c=13.5018(4)Å
α=90.00° β=92.834(2)° γ=90.00°
N-(3-Nitrophenyl)succinimide
C10H8N2O4
Acta Crystallographica Section C (2005) 61, 4 o216-o220
a=6.6318(2)Å b=7.0944(3)Å c=10.4260(5)Å
α=90.00° β=108.234(2)° γ=90.00°
4-Chloroanilinium 2-carboxy-4-nitrobenzoate
C6H7ClN,C8H4NO6
Acta Crystallographica Section C (2005) 61, 5 o276-o280
a=12.7725(16)Å b=7.5825(7)Å c=29.595(3)Å
α=90.00° β=97.202(5)° γ=90.00°
4-nitrobenzaldehyde isonicotinoylhydrazone
C13H10N4O3
Acta Crystallographica Section C (2005) 61, 12 o683-o689
a=7.7821(3)Å b=10.6633(4)Å c=14.8417(6)Å
α=90.00° β=100.799(2)° γ=90.00°
4-Amino-1-benzyl-2-(methylsulfanyl)-5-nitrosopyrimidin-6(1H)-one
C12H12N4O2S
Acta Crystallographica Section C (2003) 59, 8 o454-o460
a=10.5035(3)Å b=10.8741(3)Å c=11.8261(4)Å
α=109.6510(13)° β=96.4203(14)° γ=93.7181(14)°
2-(4-Chlorophenyl)-5-methyl-6,7-dihydrobenzo[e]pyrazolo[2,3-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=7.0098(3)Å b=15.0306(7)Å c=17.0060(8)Å
α=111.492(2)° β=101.406(3)° γ=97.981(3)°
<i>N</i>-Isopropyl-2-(methylsulfanyl)nicotinamide
C10H14N2OS
Acta Crystallographica Section C (2013) 69, 3 293-298
a=11.42(2)Å b=8.580(19)Å c=23.61(5)Å
α=90.00° β=94.15(3)° γ=90.00°
2-Amino-4-methoxy-6-(4-methoxyphenyl)-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,4]benzodiazepine
C19H17N5O2
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.6718(18)Å b=13.2928(15)Å c=15.969(2)Å
α=90.00° β=95.343(12)° γ=90.00°
3-<i>tert</i>-butyl-4',4'-dimethyl-7-(3,4-methylenedioxobenzyl)-1-phenyl- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione
C31H35N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.2691(14)Å b=11.0898(11)Å c=12.802(2)Å
α=92.844(10)° β=95.185(12)° γ=91.070(11)°
(Z)-5-(3,4,5-Trimethoxybenzylidene)-2-thioxothaolidin-2-one
C13H13NO4S2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=10.3432(4)Å b=10.9105(4)Å c=13.4621(4)Å
α=100.399(2)° β=91.572(2)° γ=110.301(2)°
4-(5-Amino-3-methyl-1H-pyrazol-1-yl)benzoic acid monohydrate
C11H11N3O2,H2O
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=8.0166(2)Å b=7.5082(2)Å c=18.5507(5)Å
α=90.00° β=91.8140(16)° γ=90.00°
3-Nitrobenzaldehyde isonicotinoylhydrazone monohydrate
C13H10N4O3,H2O
Acta Crystallographica Section C (2007) 63, 1 o42-o44
a=13.3271(5)Å b=12.7054(5)Å c=15.7748(6)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(5-amino-3-phenyl-1<i>H</i>-pyrazol-1-yl)-3-nitrobenzoate
C17H14N4O4
Acta Crystallographica Section C (2007) 63, 9 o510-o513
a=12.3516(8)Å b=7.5202(4)Å c=17.1564(13)Å
α=90.00° β=100.699(5)° γ=90.00°
Methyl 3-(2,4-dinitrophenylhydrazono)butanoate
C11H12N4O6
Acta Crystallographica Section C (2007) 63, 8 o462-o467
a=10.6100(3)Å b=12.1878(4)Å c=20.522(2)Å
α=90.00° β=90.00° γ=90.00°
2-Iodo-4-nitroaniline
C6H5IN2O2
Acta Crystallographica Section C (2001) 57, 8 942-945
a=7.1647(4)Å b=7.9572(4)Å c=8.0489(5)Å
α=67.905(3)° β=86.956(3)° γ=65.744(2)°
Benzyl 3,5-dinitrobenzoate?
C14H10N2O6
Acta Crystallographica Section C (2006) 62, 1 o26-o29
a=20.8531(5)Å b=20.8531(5)Å c=6.0377(2)Å
α=90.00° β=90.00° γ=90.00°
2-ethylsulfanyl-7-methyl-4-(4-methylphenyl)pyrazolo[1,5-a][1,3,5]triazine
C15H16N4S
Acta Crystallographica Section C (2006) 62, 3 o122-o124
a=16.0941(5)Å b=5.5573(2)Å c=15.2495(5)Å
α=90.00° β=96.2994(17)° γ=90.00°
4,5,6-Triamino-2-(methylsulfanyl)pyrimidine
C5H9N5S
Acta Crystallographica Section C (2006) 62, 3 o142-o144
a=7.7824(2)Å b=8.9623(3)Å c=10.5078(4)Å
α=90.00° β=95.261(2)° γ=90.00°
5-benzylidene-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
C13H12N2O3
Acta Crystallographica Section C (2005) 61, 5 o306-o311
a=6.1293(3)Å b=13.9633(8)Å c=13.2727(8)Å
α=90.00° β=97.688(4)° γ=90.00°
5-[4-(dimethylamino)benzylidene]-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
C15H17N3O3
Acta Crystallographica Section C (2005) 61, 5 o306-o311
a=8.6187(2)Å b=8.8451(3)Å c=9.0566(3)Å
α=82.2980(18)° β=84.465(2)° γ=82.365(2)°
7-methyl-10-phenyl-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=8.10920(10)Å b=11.7265(2)Å c=16.3486(3)Å
α=90.00° β=90.9010(12)° γ=90.00°
1-Benzyl-4-(4-nitrophenyl)-2,3-dihydro-1H-1,5-benzodiazepine
C22H19N3O2
Acta Crystallographica Section C (2005) 61, 6 o404-o407
a=7.3810(2)Å b=10.8016(3)Å c=22.1319(5)Å
α=90.00° β=90.00° γ=90.00°
3-(2-nitrobenzyl)-2-(2-nitrophenyl)-1,3-thiazolidin-4-one
C16H13N3O5S
Acta Crystallographica Section C (2007) 63, 2 o102-o107
a=22.3000(4)Å b=9.9352(3)Å c=14.6945(4)Å
α=90.00° β=96.435(2)° γ=90.00°
Morpholin-4-ium 4-amino-2-(morpholin-4-yl)-5-nitroso-6-oxo-1,6-dihydropyrimidin-1-ide
C4H10NO,C8H10N5O3
Acta Crystallographica Section C (2008) 64, 4 o220-o225
a=9.4410(11)Å b=16.347(4)Å c=18.799(5)Å
α=90.00° β=90.045(15)° γ=90.00°
Trans-Tetraaquadichloridonickel(II)--piperazine-2,5-dione (1/1)
Cl2H8NiO4,C4H6N2O2
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=9.4844(4)Å b=6.6616(3)Å c=9.9975(4)Å
α=90.00° β=114.6290(18)° γ=90.00°